BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19829130)

  • 1. Role of the CD14 C(-260)T promoter polymorphism in determining the first clinical manifestation of coronary artery disease.
    Rizzello V; Liuzzo G; Trabetti E; Di Giannuario G; Brugaletta S; Santamaria M; Piro M; Boccanelli A; Pignatti PF; Biasucci LM; Crea F
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):20-5. PubMed ID: 19829130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common polymorphisms of cyclooxygenase-2 and prostaglandin E2 receptor and increased risk for acute coronary syndrome in coronary artery disease.
    Szczeklik W; Sanak M; Rostoff P; Piwowarska W; Jakiela B; Szczeklik A
    Thromb Haemost; 2008 Nov; 100(5):893-8. PubMed ID: 18989535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cytokine gene variants in coronary artery disease patients in Greece.
    Manginas A; Tsiavou A; Chaidaroglou A; Giamouzis G; Degiannis D; Panagiotakos D; Cokkinos DV
    Coron Artery Dis; 2008 Dec; 19(8):575-82. PubMed ID: 19005292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
    Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
    Am J Cardiol; 2006 Nov; 98(9):1182-4. PubMed ID: 17056323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes.
    Arroyo-Espliguero R; El-Sharnouby K; Vázquez-Rey E; Kalidas K; Jeffery S; Kaski JC
    Int J Cardiol; 2005 Feb; 98(2):307-12. PubMed ID: 15686783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting.
    Shimada K; Miyauchi K; Mokuno H; Watanabe Y; Iwama Y; Shigekiyo M; Matsumoto M; Okazaki S; Tanimoto K; Kurata T; Sato H; Daida H
    Int J Cardiol; 2004 Mar; 94(1):87-92. PubMed ID: 14996480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum levels of inflammatory markers and allelic variant of interleukin-6 in patients with acute coronary syndrome and stable angina pectoris.
    Ozdemir O; Gundogdu F; Karakelleoglu S; Sevimli S; Pirim I; Acikel M; Arslan S; Serdar S
    Coron Artery Dis; 2008 Feb; 19(1):15-9. PubMed ID: 18281810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.
    Haberbosch W; Unkelbach K; Schuster D; Gardemann A; Tillmanns H; Hölschermann H
    Thorac Cardiovasc Surg; 2009 Oct; 57(7):386-90. PubMed ID: 19795323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide receptor CD14 polymorphism and risk of stroke in a South-German population.
    Lichy C; Meiser H; Grond-Ginsbach C; Buggle F; Dörfer C; Grau A
    J Neurol; 2002 Jul; 249(7):821-3. PubMed ID: 12140663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of -308 TNF-alpha and 1267 Hsp70-2 polymorphisms and zinc status in the susceptibility of coronary artery disease (CAD) in old patients.
    Giacconi R; Cipriano C; Muti E; Costarelli L; Malavolta M; Caruso C; Lio D; Mocchegiani E
    Biogerontology; 2006; 7(5-6):347-56. PubMed ID: 16953332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14 C(-159)T polymorphism is a risk factor for development of pulmonary tuberculosis.
    Rosas-Taraco AG; Revol A; Salinas-Carmona MC; Rendon A; Caballero-Olin G; Arce-Mendoza AY
    J Infect Dis; 2007 Dec; 196(11):1698-706. PubMed ID: 18008256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diversity of RANTES gene promoter and susceptibility to coronary artery disease and restenosis after percutaneous coronary intervention.
    Vogiatzi K; Voudris V; Apostolakis S; Kochiadakis GE; Thomopoulou S; Zaravinos A; Spandidos DA
    Thromb Res; 2009 May; 124(1):84-9. PubMed ID: 19201454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory response of coronary artery disease postmenopausal women is associated with the IVS1-397T > C estrogen receptor alpha polymorphism.
    Myśliwska J; Rutkowska A; Hak L; Siebert J; Szyndler K; Rachoń D
    Clin Immunol; 2009 Mar; 130(3):355-64. PubMed ID: 19008156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD14 gene polymorphism 159C/T in a group of patients with coronary artery disease from a population with high morbidity of cardiovascular diseases.
    Rechciński T; Grebowska A; Kurpesa M; Peruga Z; Dziuba M; Krzemińska-Pakuła M; Rudnicka W; Chmiela M
    Kardiol Pol; 2007 Mar; 65(3):237-44; discussion 245. PubMed ID: 17436151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of association between the -260 C-->T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels.
    Heesen M; Blömeke B; Schlüter B; Heussen N; Rossaint R; Kunz D
    Intensive Care Med; 2001 Nov; 27(11):1770-5. PubMed ID: 11810121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of inflammatory signaling in monocytes from patients with coronary artery disease.
    Schirmer SH; Fledderus JO; van der Laan AM; van der Pouw-Kraan TC; Moerland PD; Volger OL; Baggen JM; Böhm M; Piek JJ; Horrevoets AJ; van Royen N
    J Mol Cell Cardiol; 2009 Feb; 46(2):177-85. PubMed ID: 19059264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes.
    Rupp J; Goepel W; Kramme E; Jahn J; Solbach W; Maass M
    Genes Immun; 2004 Aug; 5(5):435-8. PubMed ID: 15175649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C(-260)>T gene polymorphism in the promoter of the CD14 monocyte receptor gene is not associated with acute myocardial infarction.
    Longobardo MT; Cefalù AB; Pezzino F; Noto D; Emmanuele G; Barbagallo CM; Fiore B; Monastero R; Castello A; Molini V; Notarbartolo A; Travali S; Averna MR
    Clin Exp Med; 2003 Nov; 3(3):161-5. PubMed ID: 14648231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 3'-UTR C>T polymorphism of the oxidized LDL-receptor 1 (OLR1) gene does not associate with coronary artery disease in Italian CAD patients or with the severity of coronary disease.
    Sentinelli F; Filippi E; Fallarino M; Romeo S; Fanelli M; Buzzetti R; Berni A; Baroni MG
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):345-52. PubMed ID: 16829343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A polymorphism in the promoter of the CD14 gene (CD14/-159) is associated with the development of coronary artery lesions in patients with Kawasaki disease.
    Nishimura S; Zaitsu M; Hara M; Yokota G; Watanabe M; Ueda Y; Imayoshi M; Ishii E; Tasaki H; Hamasaki Y
    J Pediatr; 2003 Sep; 143(3):357-62. PubMed ID: 14517520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.